covid 19 News and Research

RSS

Rapid antibody response induced by mRNA COVID vaccines in mice

A new study posted in the bioRxiv* preprint server used mouse models to investigate how mRNA vaccines elicit a rapid antibody response. Their findings show two different mRNA vaccines successfully boost antibody levels — IL-5, IL-6, and MCP-1 —5 days after administration.

7 Nov 2021

Highly-sensitive PCR-based method to detect SARS-CoV-2 variants

A team of UK-based scientists has recently developed an allele-specific probe polymerase chain reaction method that can accurately detect different variants/lineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory samples. Furthermore, the method can detect viral variants even in samples with low viral RNA or degraded viral RNA. The study is currently available on the medRxiv* preprint server.

7 Nov 2021

Pacific oyster as a weapon against SARS-CoV-2

According to an article published in the journal Reviews in Medical Virology, the effectiveness of mollusc-derived antiviral agents has been proven in many different laboratory and animal studies, while its efficacy against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been proposed by recent in silico studies.

7 Nov 2021

New data points to major SARS-CoV-2 animal reservoir in deer in Iowa

A new study tests the hypothesis that white-tailed deer are susceptible to SARS-CoV-2 infection.

7 Nov 2021

Reducing airborne transmission of infectious respiratory viruses with portable air purifiers

A new computational study focuses on the performance of portable air purifiers based on Computational Fluid Dynamics (CFD) simulations.

7 Nov 2021

The importance of exercise for those with diabetes in the COVID era

A review aims to evaluate the effectiveness of physical activity in people with type 2 diabetes and COVID-19.

7 Nov 2021

New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

The U.S. CDC reports the observed efficacy among the immunocompromised population following vaccination with mRNA vaccines against SARS-CoV-2.

7 Nov 2021

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

A new study describes a new small molecule compound that has shown impressive safety, tolerability, and bioavailability against SARS-CoV-2.

7 Nov 2021

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

A recent study assesses the boost in antibodies against SARS-CoV-2)variants post-vaccination in plasma samples from previously infected COVID-19 patients.

7 Nov 2021

SARS-CoV-2 infection amplifies immune system–related differences in dialysis, kidney transplant patients

People with kidney failure who are on dialysis or who have received a kidney transplant face a higher risk of dying from COVID-19.

7 Nov 2021

Risk factors for "long-haul" COVID in people with rheumatic diseases identified

A new study by researchers at Hospital for Special Surgery (HSS) in New York City demonstrates over half of patients with rheumatic diseases who contracted COVID-19 during the pandemic and completed a COVID-19 survey, experienced so-called "long-haul" COVID, or prolonged symptoms of the infection, including loss of taste or smell, muscle aches and difficulty concentrating, for one month or longer.

7 Nov 2021

Health and Social Care Secretary urges people in the UK to get COVID-19 booster jabs

Health and Social Care Secretary Sajid Javid has called for the UK to come together to help vaccinate those most vulnerable to COVID-19 with booster jabs.

7 Nov 2021

Booster booking system changed to make it easier for people to get their jab

The government and the NHS have changed the booster booking system to make it even easier for people to get their jab.

7 Nov 2021

GCH Pediatric Practice provides a model for addressing vaccine hesitancy and barriers

Golisano Children's Hospital Pediatric Practice in Rochester, NY demonstrated success in vaccinating eligible patients as well as their caregivers by offering the vaccine to both during pediatric visits, and provides a model for addressing vaccine hesitancy and barriers, according to an October 8th article published in JAMA Pediatrics' Viewpoint.

7 Nov 2021